American Journal of Transplantation
BETA-2 Score is an Early Predictor of Graft Decline and Loss of Insulin Independence After Pancreatic Islet Allotransplantation
BETA-2 Calculated Based on Single Fasting Blood Sample Allows to Define and Discriminate between Optimal and Suboptimal Islet Allograft Function Prior to the Clinical Need for Insulin Support.
Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study